Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Analysis and function of prototype foamy virus envelope N glycosylation.
J Virol. 2005 Jun;79(12):7664-72. doi: 10.1128/JVI.79.12.7664-7672.2005.
J Virol. 2005.
PMID: 15919919
Free PMC article.
Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.
Duda A, Stange A, Lüftenegger D, Stanke N, Westphal D, Pietschmann T, Eastman SW, Linial ML, Rethwilm A, Lindemann D.
Duda A, et al. Among authors: luftenegger d.
J Virol. 2004 Dec;78(24):13865-70. doi: 10.1128/JVI.78.24.13865-13870.2004.
J Virol. 2004.
PMID: 15564494
Free PMC article.
Item in Clipboard
Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release.
Stanke N, Stange A, Lüftenegger D, Zentgraf H, Lindemann D.
Stanke N, et al. Among authors: luftenegger d.
J Virol. 2005 Dec;79(24):15074-83. doi: 10.1128/JVI.79.24.15074-15083.2005.
J Virol. 2005.
PMID: 16306578
Free PMC article.
Item in Clipboard
Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
Duda A, Lüftenegger D, Pietschmann T, Lindemann D.
Duda A, et al. Among authors: luftenegger d.
J Virol. 2006 Aug;80(16):8158-67. doi: 10.1128/JVI.00460-06.
J Virol. 2006.
PMID: 16873272
Free PMC article.
Item in Clipboard
Subviral particle release determinants of prototype foamy virus.
Stange A, Lüftenegger D, Reh J, Weissenhorn W, Lindemann D.
Stange A, et al. Among authors: luftenegger d.
J Virol. 2008 Oct;82(20):9858-69. doi: 10.1128/JVI.00949-08. Epub 2008 Aug 6.
J Virol. 2008.
PMID: 18684814
Free PMC article.
Item in Clipboard
Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.
Stirnnagel K, Lüftenegger D, Stange A, Swiersy A, Müllers E, Reh J, Stanke N, Grosse A, Chiantia S, Keller H, Schwille P, Hanenberg H, Zentgraf H, Lindemann D.
Stirnnagel K, et al. Among authors: luftenegger d.
Retrovirology. 2010 May 17;7:45. doi: 10.1186/1742-4690-7-45.
Retrovirology. 2010.
PMID: 20478027
Free PMC article.
Item in Clipboard
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm N, Ellenberger D, Stahmann A, Fneish F, Lüftenegger D, Salmen HC, Schirduan K, Schaak TPA, Flachenecker P, Kleinschnitz C, Paul F, Krefting D, Zettl UK, Peters M, Warnke C.
Frahm N, et al. Among authors: luftenegger d.
Ther Adv Neurol Disord. 2024 Mar 29;17:17562864241239740. doi: 10.1177/17562864241239740. eCollection 2024.
Ther Adv Neurol Disord. 2024.
PMID: 38560408
Free PMC article.
Item in Clipboard
Inhibition of the proteasome influences murine and human dendritic cell development in vitro and in vivo.
Zinser E, Rössner S, Littmann L, Lüftenegger D, Schubert U, Steinkasserer A.
Zinser E, et al. Among authors: luftenegger d.
Immunobiology. 2009;214(9-10):843-51. doi: 10.1016/j.imbio.2009.06.018. Epub 2009 Jul 22.
Immunobiology. 2009.
PMID: 19628298
Item in Clipboard
Cite
Cite